HIGHLIGHTS
- who: Ying-Ming Chiu from the Hospital, Nanxiao St, Changhua, Taiwan University, Taichung, Taiwan have published the research work: Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study, in the Journal: (JOURNAL) of 30/06/2012
- what: This study, which was conducted in an HBV endemic region, is the first to have determined the relative risk of liver enzyme elevation in large cohorts of anti-TNF users with differing HBV serostatus, controlling for potential risk factors.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.